W Vaudry Selected Research

Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)

1/2022

Clinical Presentations and Outcomes of Children in Canada With Recurrent Invasive Pneumococcal Disease From the IMPACT Surveillance Network.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

W Vaudry Research Topics

Disease

2	Pneumococcal Infections 01/2022 - 07/2001
2	Necrosis 01/2021 - 11/2003
2	Human Influenza (Influenza) 06/2018 - 05/2017
2	Infections 07/2001 - 11/2000
1	Inflammation (Inflammations) 01/2021
1	Neural Tube Defects (Exencephaly) 10/2019
1	Vaccine-Preventable Diseases 12/2014
1	Exanthema (Rash) 11/2000
1	Chickenpox 11/2000
1	Poliomyelitis (Polio) 05/2000
1	Tetanus 05/2000
1	Diphtheria 05/2000
1	Whooping Cough (Pertussis) 05/2000

Drug/Important Bio-Agent (IBA)

5	VaccinesIBA 01/2022 - 05/2000
2	Influenza Vaccines (Influenza Vaccine)FDA Link 06/2018 - 05/2017
2	Conjugate VaccinesIBA 07/2001 - 05/2000
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2022
1	EndoglinIBA 01/2021
1	EnzymesIBA 01/2021
1	Angiopoietin-2IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	dolutegravirIBA 10/2019
1	OvalbuminIBA 05/2017
1	Penicillins (Penicillin)FDA Link 07/2001
1	Chickenpox Vaccine (Vaccine, Varicella)IBA 11/2000
1	Acyclovir (Aciclovir)FDA LinkGeneric 11/2000
1	Haemophilus influenza type b polysaccharide vaccine-tetanus toxin conjugate (ActHIB)IBA 05/2000
1	PENTAIBA 05/2000
1	Phosphates (Orthophosphate)IBA 05/2000
1	Proteins (Proteins, Gene)FDA Link 05/2000
1	RibitolIBA 05/2000
1	Diphtheria-Tetanus-Pertussis Vaccine (DPT Vaccine)IBA 05/2000

Therapy/Procedure

1	Debridement 11/2003
1	Therapeutics 11/2000